The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
Open accessAbstract
The melanoma cell line FO-1 does not express HLA class I antigens and does not acquire them on the cell surface after incubation with IFN-gamma. Immunochemical studies showed that FO-1 cells synthesize HLA class I heavy chain, but do not synthesize beta 2-microglobulin (beta 2-mu). The latter abnormality is associated with lack of beta 2-mu mRNA which remains undetectable in FO-1 cells incubated with IFN-gamma. The defect was identified as a genetic lesion in the B2m gene, since DNA hybridization analysis detected a deletion of the first exon of the 5'-flanking region, and of a segment of the first intron of the B2m gene. HLA class I antigen expression was reconstituted on melanoma cells FO-1 after transfection with the wild-type mouse B2m gene, thereby confirming the abnormality of the endogenous B2m gene. The defect identified in FO-1 cells is distinct from that underlying the lack of HLA class I antigen expression by lymphoblastoid cells Daudi, but is remarkably similar to that causing lack of H-2 class I antigen expression by mouse lymphoblastoid cells R1 (TL-). These results suggest that genetic recombination in the 5' region of the B2m gene is a recurrent mechanism in B2m gene defects. In addition to contributing to our understanding of molecular abnormalities in HLA class I antigen expression by melanoma cells, FO-1 cells represent a useful model for analyzing the role of HLA class I antigens in the biology of melanoma cells and in their interaction with cells of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A Film Detection Method for Tritium‐Labelled Proteins and Nucleic Acids in Polyacrylamide Gels
BONNER, W. M., & LASKEY, R. A. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03599.x · Cited by 8,589
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,915
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,558
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., & Bunn, P. A. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90435-6 · Cited by 943
Potter, H., Weir, L., & Leder, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7161 · Cited by 866
Detection of specific sequences among DNA fragments separated by gel electrophoresis. 1975.
Southern, E. M. (1992) · PubMed · Cited by 526
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules
Ploegh, H. L., Orr, H. T., & Strominger, J. L. (1981) · Cell · doi:10.1016/0092-8674(81)90318-4 · Cited by 520
NK susceptibility varies inversely with target cell class I HLA antigen expression.
Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R., & Cresswell, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1657 · Cited by 429
Suggs, S. V., Wallace, R. B., Hirose, T., Kawashima, E. H., & Itakura, K. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6613 · Cited by 417
Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
Wallach, D., Fellous, M., & Revel, M. (1982) · Nature · doi:10.1038/299833a0 · Cited by 383
Doyle, A., Martin, W. J., Funa, K., Gazdar, A., Carney, D., Martin, S. E., Linnoila, I., Cuttitta, F., Mulshine, J., & Bunn, P. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1135 · Cited by 382
Sood, A. K., Pereira, D., & Weissman, S. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.616 · Cited by 363
Johnson, J. P., Stade, B. G., Holzmann, B., Schwäble, W., & Riethmüller, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.641 · Cited by 359
The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319
Brodsky, F. M., Bodmer, W. F., & Parham, P. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090709 · Cited by 304
Shimizu, Y., & DeMars, R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.9.3320 · Cited by 293
Natali, P. G., Nicotra, M., Cavaliere, R., et al. (1990) · PubMed · Cited by 273
The β2-microglobulin gene is on chromosome 15 and not in the HL-A region
GOODFELLOW, P. N., JONES, E. A., VAN HEYNINGEN, V., SOLOMON, E., BOBROW, M., MIGGIANO, V., & BODMER, W. F. (1975) · Nature · doi:10.1038/254267a0 · Cited by 272
c-myc down-regulates class I HLA expression in human melanomas.
Versteeg, R., Noordermeer, I. A., Krüse-Wolters, M., Ruiter, D. J., & Schrier, P. I. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02909.x · Cited by 252
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.
Kavathas, P., Bach, F. H., & DeMars, R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4251 · Cited by 252
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.
Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R., & Cresswell, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2361 · Cited by 236
Arce‐Gomez, B., Jones, E. A., Barnstable, C. J., Solomon, E., & Bodmer, W. F. (1978) · Tissue Antigens · doi:10.1111/j.1399-0039.1978.tb01233.x · Cited by 221
Allen, H., Fraser, J., Flyer, D., Calvin, S., & Flavell, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7447 · Cited by 209
Role Of The Major Histocompatibility Complex Class I Antigens In Tumor Growth And Metastasis
Tanaka, K. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.359 · Cited by 200
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
DeMars, R., Rudersdorf, R., Chang, C., Petersen, J., Strandtmann, J., Korn, N., Sidwell, B., & Orr, H. T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8183 · Cited by 181
Harel‐Bellan, A., Quillet‐Mary, A., Marchiol, C., DeMars, R., Tursz, T., & FRADELIZI, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5688 · Cited by 142
van Duinen, S. G., Dj, R., Broecker, E.-B., van der Velde, Sorg, C., Welvaart, K., & Ferrone, S. (1988) · PubMed · Cited by 138
Self-citationGuanidine Isothiocyanate Preparation of Total RNA
Davis, L. G., Dibner, M. D., & Battey, J. F. (1986) · Elsevier eBooks · doi:10.1016/b978-0-444-01082-7.50040-0 · Cited by 135
Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji, B., Guha, A. A., Chakraborty, N. G., Sivanandham, M., Nashed, A. L., Sporn, J., & Ergin, M. T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.6.1961 · Cited by 128
TEMPONI, M., Kageshita, T., Perosa, F., Ono, R., OKADA, H., & Ferrone, S. (1989) · Hybridoma · doi:10.1089/hyb.1989.8.85 · Cited by 122
Self-citationPELLEGRINO, M. A., Ng, A., RUSSO, C., & Ferrone, S. (1982) · Transplantation · doi:10.1097/00007890-198207000-00004 · Cited by 119
Self-citationSuppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
Versteeg, R., Krüse, K. M., Plomp, A. C., LEEUWEN, A. V., Stam, N. J., Ploegh, H. L., Ruiter, D. J., & Schrier, P. I. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.3.621 · Cited by 111
Quillet, A., Presse, F., Marchiol, C., Harel‐Bellan, A., Benbunan, M., Ploegh, H. L., & FRADELIZI, D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.1.17 · Cited by 108
Matsui, M., TEMPONI, M., & Ferrone, S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.2088 · Cited by 96
Self-citationRegulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation.
Turco, M. C., Felice, M. D., Corbo, L., Morrone, G., Mertelsmann, R., Ferrone, S., & Venuta, S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2268 · Cited by 80
Self-citationRescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin gene.
Seong, R. H., Clayberger, C., Krensky, A. M., & Parnes, J. R. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.2.288 · Cited by 80
Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.
Potter, T. A., Boyer, C., Verhulst, A. M., Golstein, P., & Rajan, T. V. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.160.1.317 · Cited by 70
High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
Versteeg, R., Peltenburg, L. T. C., Plomp, A. C., & Schrier, P. I. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.4331 · Cited by 49
Sunday, M. E., Isselbacher, K. J., Gattoni‐Celli, S., & Willett, C. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4700 · Cited by 22
Cited by
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Tumour-intrinsic resistance to immune checkpoint blockade
Kalbasi, A., & Ribas, A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,486
Metadata
- Authors
- D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., & Ferrone, S.
- Venue
- Journal of Clinical Investigation
- Published
- 1991-01-01
- Volume
- 87
- Issue
- 1
- Pages
- 284-292
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2154298769
- Cited by
- 309
- References
- 46
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.